LGALS3 and Myocardial fibrosis: So, in the 2013 study, researchers found that galectin-3 plays a significant role in myocardial fibrosis, which determines the transition from compensated to decompensated heart failure, thus highlighting the clinical importance of the correlation between galectin-3 and HFpEF development [13].